Lowering of HDL cholesterol in post-menopausal women by tibolone is not associated with changes in cholesterol efflux capacity or paraoxonase activity
- 1 December 2001
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 159 (2) , 433-439
- https://doi.org/10.1016/s0021-9150(01)00522-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- High Density Lipoproteins and ArteriosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Resistance of pelvic arteries and plasma lipids in postmenopausal women: Comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapyAmerican Journal of Obstetrics and Gynecology, 2000
- 1999 George Lyman Duff Memorial LectureArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Does paraoxonase play a role in susceptibility to cardiovascular disease?Molecular Medicine Today, 1999
- Tibolone: a reviewMaturitas, 1998
- Paraoxonase and coronary heart diseaseCurrent Opinion in Lipidology, 1998
- Insulin resistance and coronary heart diseaseCurrent Opinion in Lipidology, 1996
- Physiological role and clinical relevance of high-density lipoprotein subclassesCurrent Opinion in Lipidology, 1994
- Relation of components of insulin resistance syndrome to coronary disease riskCurrent Opinion in Lipidology, 1994
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesNew England Journal of Medicine, 1989